Skip to content
Ian Poburenny
Director
Rothschild & Co
Ian is a Director at Rothschild & Co focusing on healthcare services and nuclear medicine. Based in London, he advises investors, corporates and business owners on M&A, IPO and financing transactions across Europe, the US and the Middle East. He recently advised on the sale of Medivet, Ergea, Sanoptis, PharmaLogic, Curium and Priory
For more amazing speakers
HBI 2024 will be full of amazing people like this. See who else will be speaking.
